#United States #diagnostics #Anaheim #bioMérieux #ADLM 2026

bioMérieux to Showcase Latest Innovations at ADLM 2026

bioMérieux, a renowned leader in the field of in vitro diagnostics, is set to exhibit its newest diagnostic solutions during the annual ADLM 2026 Conference, taking place from July 26-30 in Anaheim, California. This important event serves as a platform for bioMérieux to connect with professionals across clinical microbiology, molecular diagnostics, and laboratory informatics.

A Legacy of Leadership

The theme for this year's presentation, "A legacy of diagnostic leadership. Your partner for what's ahead," embodies bioMérieux's unwavering commitment to delivering excellence in diagnostics throughout its 63-year history. Attendees are encouraged to visit Booth #2501 in Hall B, where they can engage with experts and explore the comprehensive portfolio of solutions provided by the company.

Cutting-Edge Technologies

At the expo, bioMérieux will highlight several groundbreaking platforms, designed to enhance laboratory operations and patient care. Featured technologies include:

• - BIOFIRE® FILMARRAY® TORCH System: This multiplex PCR technology significantly speeds up testing by allowing for a comprehensive analysis of multiple targets in under an hour.
• - BIOFIRE® SPOTFIRE® System: A key addition that provides reliable diagnostics in point-of-care clinical environments.
• - VITEK® MS PRIME: This mass spectrometry system streamlines routine microbial identification, increasing diagnostic accuracy.
• - VIDAS® 3: An automated immunoassay system designed to improve workflow efficiency in laboratory settings.

These innovations showcase how bioMérieux's solutions seamlessly integrate microbiology and molecular diagnostics with laboratory automation and informatics. This synergy aids laboratories in enhancing operational efficiency, expediting decision-making, and ultimately optimizing patient care. Additionally, visitors will have the chance to investigate bioMérieux's latest IT solutions and Lab Consultancy services aimed at driving digital transformation and improving health outcomes.

Educational Opportunities

bioMérieux is also committed to advancing clinical knowledge through symposiums scheduled during the conference. Two notable symposiums include:
1. From Central Lab to POC: Rethinking Vaginitis Diagnostics
- Date & Time: Tuesday, July 28, from 12:00 PM to 12:20 PM
- Location: Exhibit Hall Theater 2
- Focus: Examining current diagnostic limitations and exploring how point-of-care testing can improve real-time decision-making.

2. The Syndromic Standard: Explore the Clinical Impact of MPCR GI Panels for Gastroenteritis
- Date & Time: Tuesday, July 28, from 2:45 PM to 3:35 PM
- Location: Exhibit Hall Theater 1
- Focus: Discussing new developments to reduce diagnostic uncertainty and enhance patient outcomes.

Press Conference and Panel Discussion

In addition to the educational events, bioMérieux will host a press conference panel titled, The Power of Diagnostics: How Delays Impact Patients and Providers. Scheduled for Wednesday, July 29, from 9:00 AM to 9:45 AM in Room 213D, this panel will feature experts discussing the ramifications of delays and inaccuracies in diagnostics, particularly among underserved populations. Real-world examples and potential solutions will be shared, highlighting the importance of timely and accurate diagnostic information.

Conclusion

All attendees and media representatives are welcome to participate in these invaluable sessions at ADLM 2026. For media registration, visit ADLM Media Registration. For additional information regarding the press conference, reach out to bioMérieux via email at [email protected].

bioMérieux has been a trailblazer in in vitro diagnostics since 1963, operating in 46 countries and serving over 160 nations globally. With 94% of its sales deriving from international markets, bioMérieux continues to provide critical diagnostic solutions to enhance patient health and ensure consumer safety. Explore more at www.biomerieux.com.